These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 14976565)

  • 1. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
    Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
    J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
    Calvet X; Ducons J; Bujanda L; Bory F; Montserrat A; Gisbert JP;
    Am J Gastroenterol; 2005 Aug; 100(8):1696-701. PubMed ID: 16086704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
    Choi BK; Yang SY; Park ET; Jang YS; Lee YJ; Lee SH; Seol SY; Chung JM
    Korean J Gastroenterol; 2003 Aug; 42(2):102-7. PubMed ID: 14532713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
    Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
    World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
    Gambaro C; Bilardi C; Dulbecco P; Iiritano E; Zentilin P; Mansia C; Usai P; Vigneri S; Savarino V
    Dig Liver Dis; 2003 Nov; 35(11):763-7. PubMed ID: 14674665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
    Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven-day therapy for Helicobacter pylori in the United States.
    Vakil N; Lanza F; Schwartz H; Barth J
    Aliment Pharmacol Ther; 2004 Jul; 20(1):99-107. PubMed ID: 15225176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection.
    Kositchaiwat C; Ovartlarnporn B; Kachintorn U; Atisook K
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1017-21. PubMed ID: 14616168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.
    Sharara AI; Chaar HF; Racoubian E; Moukhachen O; Barada KA; Mourad FH; Araj GF
    Helicobacter; 2004 Jun; 9(3):255-61. PubMed ID: 15165262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
    De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
    Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
    Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
    Wong BC; Wong WM; Yee YK; Hung WK; Yip AW; Szeto ML; Li KF; Lau P; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Hui CK; Lam SK
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1959-65. PubMed ID: 11736727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
    Zullo A; Gatta L; De Francesco V; Hassan C; Ricci C; Bernabucci V; Cavina M; Ierardi E; Morini S; Vaira D
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1419-24. PubMed ID: 15948808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
    Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
    Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.
    Wang HH; Chou JW; Liao KF; Lin ZY; Lai HC; Hsu CH; Chen CB
    World J Gastroenterol; 2005 Mar; 11(11):1680-4. PubMed ID: 15786549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.